A Closer Look: Ambrx Doubles Down In China With Hisun Deal
This article was originally published in PharmAsia News
Executive Summary
San Diego-based Ambrx is aggressively striking deals with companies in China. PharmAsia News takes a closer look at a recent deal with Hisun and adds background to its growing ties to Big Pharma.